Symbiosis Pharmaceutical Services
symBiosis GmbH is a prominent supplier to the pharmaceutical industry, specialising in providing comprehensive regulatory and analytical services.
Description
Symbiosis Pharmaceutical Services is a Scotland-based contract manufacturing organisation (CMO) specialising in rapid access to sterile fill-finish manufacturing for biologics and small molecules.
Established in 2011, Symbiosis Pharmaceutical Services has positioned itself as a leading provider of GMP aseptic manufacturing solutions. Headquartered in Stirling, Scotland, with an additional office in Cambridge, Massachusetts, USA, the company offers global reach and expertise. Symbiosis is committed to accelerating clients' drug development timelines by providing rapid access to manufacturing slots within weeks, not months, ensuring critical projects are delivered on time and to the highest quality standards. The company's purpose-built, MHRA-licensed facility has successfully delivered over 1,000 projects, encompassing a diverse range of products such as monoclonal antibodies (mAbs), advanced therapy medicinal products (ATMPs), vaccines, peptides, RNA, antibody-drug conjugates (ADCs), and small molecules.
Key Products and Services:
Sterile Fill-Finish/Aseptic Filling: Expertise in the sterile filling of liquid and lyophilised investigational and commercial products, ensuring safe and reliable drug product administration.
Bulk Lyophilisation: Integration of lyophilisation or gas overlay to liquid fill options as part of the aseptic filling process within their GMP facility.
Drug Product Testing: Comprehensive coordination of analytical and microbiological testing requirements, maintaining drug product integrity and accelerating delivery timelines.
Qualified Person (QP) Release: Certification of clinical and commercial batches, supporting QP certification for clinic or direct client delivery for onward processing.
Clinical Label/Pack: Dedicated suites and automation capabilities for the labelling and packaging of drug products intended for clinical trials.
Product Development: Support in overcoming development and manufacturing challenges, particularly for highly potent ADCs, with experienced handling of complex products from manufacture to QP release.
Symbiosis Pharmaceutical Services continues to expand its capabilities and facilities to meet the evolving needs of the biopharmaceutical industry. With a steadfast commitment to quality, innovation, and client satisfaction, Symbiosis remains a trusted partner for pharmaceutical companies worldwide, dedicated to bringing life-changing therapies to patients faster.